Iovance Biotherapeutics Inc

Financials

İşletme faaliyetlerinden elde edilen nakit -73.3 M-103.69 M-67.45 M-78.7 M-52.56 M -302.41 M Yatırım faaliyetlerinden elde edilen nakit 23.68 M15.87 M13.84 M17.01 M775 K 47.5 M Finansman faaliyetlerinden elde edilen nakit 2.31 M143.31 M13.23 M88.06 M56.17 M 300.77 M Free cash flow -77.46 M-109.91 M-74.91 M-89.55 M-61.88 M -336.24 M

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer.

IOVA

Financials

Iovance Biotherapeutics Inc

Haberler

Undercovered Stocks: Zscaler, Aeluma, Devon Energy, And More

Jefferies, Iovance Biotherapeutics için al tavsiyesini tekrarladı

Iovance Biotherapeutics: Positioned For Multi-Year Growth, Buy The Pullback (NASDAQ:IOVA)

Iovance Biotherapeutics: Competition Afoot, But New Indications Can Help (NASDAQ:IOVA)

Iovance Biotherapeutics (IOVA) Down 2.1% Since Last Earnings Report: Can It Rebound?

Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock?

Iovance Biotherapeutics yönetim kurulu üyesi Wendy Yarno görev süresi sonunda emekli olacak

Iovance Biotherapeutics Barclays Konferansı: Büyüme ve Zorluklar

Iovance Biotherapeutics at Barclays Conference: Strategic Growth and Challenges

What's Going On With Iovance Biotherapeutics Stock On Friday? - Iovance Biotherapeutics (NASDAQ:IOVA)

Iovance Biotherapeutics hissesi 4,35 dolarda zirve yaptı

Iovance Biotherapeutics stock hits 52-week high at 4.35 USD